Medical devices, healthcare technology and the business of care
PMA approval · P060001

PROTEGE GPS AND PROTEGE RX CAROTID STENT SYSTEMS

Medtronic Vascular, Inc. · Decision date Jan 24, 2007

FDA DECISIONP060001

What did the FDA approve?

FDA records P060001 as an original PMA application. The recorded decision is approval, dated Jan 24, 2007.

FDA approval order statement

APPROVAL FOR THE PROTEGE GPS AND PROTEGE RX CAROTID STENT SYSTEMS. THIS DEVICE IS INDICATED FOR USED IN CONJUNCTION WITH EV3 EMBOLIC PROTECTION DEVICES, ARE INDICATED FOR THE TREATMENT OF PATIENTS AT HIGH RISK FOR ADVERSE EVENTS FROM CAROTID ENDARTERECTOMY WHO REQUIRE PERCUTANEOUS CAROTID REVASCULARIZATION AND MEET THE FOLLOWING CRITERIA:1) PATIENTS WITH CAROTID ARTERY STENOSIS (>= 50% FOR SYMPTOMATIC PATIENTS BY ULTRASOUND OR ANGIOGRAPHY OR >= 80% FOR ASYMPTOMATIC PATIENTS BY ULTRASOUND OR ANGIOGRAPHY) OF THE COMMON OR INTERNAL CAROTID ARTERY, AND2) PATIENTS MUST HAVE A REFERENCE VESSEL DIAMETER WITHIN THE RANGE OF 4.5 MM AND 9.5 MM AT THE TARGET LESION.
Regulatory pathway
Original PMA
Clinical specialty
Cardiovascular
Decision date
Jan 24, 2007

FDA source record

Regulatory record facts

Identifier
P060001
Regulatory pathway
Premarket approval application
Product code
NIM
Decision code
APPR
Decision date
Jan 24, 2007
Source update
Nov 9, 2026
Original record
Open FDA source record

About this medical device

FDA device category: Stent, carotid.

Product code
NIM
FDA device class
3

The approval statement above describes the scope recorded for this original decision. Later supplements may change the device or its indications.

FDA decision timeline

  1. P060001 received

    Application receipt date recorded by FDA.

  2. P060001 · FDA decision

    APPR

  3. P060001/S059 · Related supplement

    Protégé GPS Self-Expanding Peripheral Stent System; Protégé RX Self-Expanding Carotid Stent System

  4. P060001/S060 · Related supplement

    PROTEGE GPS AND PROTEGE RX CAROTID STENT SYSTEMS

Timeline entries are records held by MedtechLedger for P060001. View FDA’s full supplement list.

Related devices and submissions

Same PMA: P060001

Explore the linked device profile

Other records with product code NIM

A shared product code identifies a classification relationship; it does not establish clinical equivalence.

Regulatory context

An original PMA is a premarket approval application. The recorded approval scope is described in FDA’s order and supporting documents.

Read our guide to FDA clearance and approval · FDA’s explanation of this pathway

Manufacturer intelligence

Medtronic Vascular, Inc.

Headquarters
Not reported
Brand website
medtronic.com
FDA applicant address
3033 Campus Dr., Plymouth, MN, 55441

Sources and methodology

FDA fields and approval-order wording are presented as source information. MedtechLedger explanations are identified separately and describe the scope of the recorded decision. Indications from an original PMA are historical unless confirmed against subsequent labeling and supplements.

How we use FDA records